| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |